CA
CNMD icon

Clearstead Advisors’s CONMED CNMD Stock Holding History

Clearstead Advisors’s Portfolio CNMD Stock Details CNMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-2,500
Closed -$130K – 3125
2025
Q2 		$130K Hold
2,500
– – ﹤0.01% 989
2025
Q1 		$151K Sell
2,500
-71
-3% -$4.58K ﹤0.01% 893
2024
Q4 		$176K Sell
2,571
-20
-0.8% -$1.39K ﹤0.01% 891
2024
Q3 		$186K Hold
2,591
– – ﹤0.01% 877
2024
Q2 		$180K Buy
2,591
+2,543
+5,298% +$186K ﹤0.01% 846
2024
Q1 		$3.5K Hold
48
– – ﹤0.01% 1230
2023
Q4 		$5.26K Sell
48
-4
-8% -$414 ﹤0.01% 1159
2023
Q3 		$5.25K Buy
+52
New +$5.97K ﹤0.01% 1231

Other funds holding CNMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
WHG
Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Clearstead Advisors's CNMD Position: Q3 2025 in Review

Clearstead Advisors sold out of CONMED (CNMD) in Q3 2025, closing a stake of 2,500 shares — an estimated $130K sold.

Clearstead Advisors first reported a position in CNMD in Q3 2023 and held it in 8 quarters. The position peaked at $186K in Q3 2024. 273 funds tracked by Wall St. Rank hold CNMD as of Q3 2025.

  • Clearstead Advisors reported no remaining CONMED position as of Q3 2025 after selling out during the quarter.
  • Clearstead Advisors sold 2,500 CONMED shares in Q3 2025, an estimated $130K.
  • Clearstead Advisors first reported a position in CONMED in Q3 2023 and held it in 8 quarters.
  • Clearstead Advisors's CONMED position peaked at $186K in Q3 2024.
  • 273 funds tracked by Wall St. Rank held CONMED as of Q3 2025.

Based on Clearstead Advisors's 13F filing for Q3 2025, filed 10 Nov 2025.